Plain-English translation of NCT07146503 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an observational study that follows people with treatment-resistant depression—depression that hasn't improved with at least two other antidepressants—who are now being treated with esketamine nasal spray. The study tracks how well the medication works, who benefits most from it, and how it affects your daily life, relationships, and ability to work or do activities you care about.
Many people with depression find that standard antidepressants don't help them. This study exists to understand whether this medication can help people whose depression has been hard to treat, and to learn which patients are most likely to improve so doctors can better match treatments to individual patients.
You likely qualify if…
You likely don't qualify if…
You will be monitored over time as you use the nasal spray medication under your doctor's care. The study will collect information about how you're responding to treatment, how your mood and daily functioning are changing, and may include interviews, questionnaires, and possibly biological samples (like blood tests) or brain imaging to help researchers understand how the medication is working. Your real-world experience—how the treatment fits into your daily life—is what the researchers are most interested in learning about.
AI-generated summary from trial data · Jun 26, 2026 · Not medical advice
Italy